IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX)

CUSIP: 4525EP101

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
140,994,040
Total 13F shares
2,155,699
Share change
+17,355
Total reported value
$13,039,030
Price per share
$6.01
Number of holders
15
Value change
+$104,044
Number of buys
7
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 4525EP101?
CUSIP 4525EP101 identifies IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Omega Fund Management, LLC
13F
Company
0.97%
1,371,494
$13,303,000 31 Dec 2019
13F
Artal Group S.A.
13F
Company
0.45%
630,019
$6,111,000 31 Dec 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
60,631
$588,000 31 Dec 2019
13F
BlackRock Finance, Inc.
13F
Company
0.02%
34,001
$330,000 31 Dec 2019
13F
VANGUARD GROUP INC
13F
Company
0.01%
11,520
$112,000 31 Dec 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.01%
11,463
$111,000 31 Dec 2019
13F
Verition Fund Management LLC
13F
Company
0.01%
11,301
$110,000 31 Dec 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
6,029
$59,000 31 Dec 2019
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,300
$13,000 31 Dec 2019
13F
DEUTSCHE BANK AG\
13F
Company
0%
402
$3,000 31 Dec 2019
13F
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC
13F
Company
0%
297
$3,000 31 Dec 2019
13F
MEEDER ASSET MANAGEMENT INC
13F
Company
0%
212
$2,000 31 Dec 2019
13F
MORGAN STANLEY
13F
Company
0%
122
$1,000 31 Dec 2019
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0%
72
$1,000 31 Dec 2019
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
5
$48 31 Dec 2019
13F

Institutional Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q1 2020

As of 31 Mar 2020, IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,155,699 shares. The largest 10 holders included Omega Fund Management, LLC, Artal Group S.A., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, Verition Fund Management LLC, WELLS FARGO & COMPANY/MN, MILLENNIUM MANAGEMENT LLC, UBS Group AG, and BANK OF AMERICA CORP /DE/. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
14
Q1 2020 holders
15
Holder diff
1
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 Value $ Q1 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.